`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`HIKMA PHARMACEUTICALS USA INC.,
`HIKMA PHARMACEUTICALS PLC,
`Petitioner,
`
`v.
`
`AMARIN PHARMACEUTICALS IRELAND LIMITED,
`Patent Owner.
`
`
`Case IPR2022-00215
`Patent 8,642,077 B2
`Issued: February 4, 2014
`
`Title: STABLE PHARMACEUTICAL
`COMPOSITION AND METHODS OF USING SAME
`
`
`PETITIONER’S POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2022-00215 (8,642,077 B2)
`
`Pursuant to 37 C.F.R. § 42.10(b), Hikma Pharmaceuticals USA Inc. and
`
`Hikma Pharmaceuticals PLC (collectively, “Petitioner”) appoint the following
`
`practitioners as attorneys to prosecute and transact all business in the Patent Trial
`
`and Appeal Board of the United States Patent and Trademark Office in connection
`
`with the above-captioned Petition for Inter Partes Review:
`
`1. Jovial Wong (Reg. No. 60,115) – Lead Counsel
`
`WINSTON & STRAWN LLP
`
`1901 L Street NW
`
`Washington, DC 20036
`
`Telephone: 202-282-5000
`
`Fax: 202-282-5100
`
`Email: JWong@winston.com
`
`2. Charles B. Klein (pro hac vice to be submitted) – Back-Up Counsel
`
`WINSTON & STRAWN LLP
`
`1901 L Street NW
`
`Washington, DC 20036
`
`Telephone: 202-282-5000
`
`Fax: 202-282-5100
`
`Email: CKlein@winston.com
`
`3. Eimeric Reig-Plessis (pro hac vice to be submitted) – Back-Up Counsel
`
`
`
`IPR2022-00215 (8,642,077 B2)
`
`WINSTON & STRAWN LLP
`
`101 California Street
`
`San Francisco, CA 94111
`
`Telephone: (415) 591-1000
`
`Facsimile: (415) 591-1400
`
`Email: EReigPlessis@winston.com
`
`4. Claire A. Fundakowski (pro hac vice to be submitted) – Back-Up Counsel
`
`WINSTON & STRAWN LLP
`
`1901 L Street NW
`
`Washington, DC 20036
`
`Telephone: 202-282-5000
`
`Fax: 202-282-5100
`
`Email: CFundakowski@winston.com
`
`5. Alison M. King (Reg. No. 76,897) – Back-Up Counsel
`
`WINSTON & STRAWN LLP
`
`35 W. Wacker Drive
`
`Chicago, IL 60601
`
`Tel: (312) 558-5600
`
`Fax: (312) 558-5700
`
`Email: AMKing@winston.com
`
`2
`
`
`
`IPR2022-00215 (8,642,077 B2)
`
`The undersigned is authorized to sign this Power of Attorney on behalf of
`
`Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals PLC.
`
`Executed at
`
`Cherry Hill, New Jersey
`
`29
` on November___, 2021
`
`Signature:
`
`Printed
`Name:
`
`Samuel S. Park
`
`Title:
`
`U.S. General Counsel and Global Head, IP
`
`3
`
`